Teladoc Health Inc buy Royal Bank of Canada
Start price
24.01.25
/
50%
€9.70
Target price
24.01.26
€11.43
Performance (%)
-34.35%
Price
19:11
€6.37
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Teladoc Health Inc is performing very badly with a performance of -34.35%. This prediction currently runs until 24.01.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Teladoc Health Inc | -1.334% | -1.334% |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Teladoc Health Inc diskutieren
Teladoc Health, Inc. (NYSE: TDOC) had its price target raised by analysts at Royal Bank of Canada from $11.00 to $12.00. They now have an "outperform" rating on the stock.
Ratings data for TDOC provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Teladoc Health Inc
Teladoc Health Inc
Start price
Target price
Perf. (%)
€12.29
26.04.24
26.04.24
€16.82
26.04.25
26.04.25
-48.06%
27.04.25
27.04.25
Teladoc Health Inc
Start price
Target price
Perf. (%)
€14.32
21.02.24
21.02.24
€23.12
21.02.25
21.02.25
-24.01%
22.02.25
22.02.25
Teladoc Health Inc
Start price
Target price
Perf. (%)
€16.46
25.10.23
25.10.23
€28.38
25.10.24
25.10.24
-52.00%
26.10.24
26.10.24